Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ATYR

aTYR PHARMA (ATYR) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $0.25 -3.5% on the day -74.2% over 12 months 52-week range $0.25 – $1.06

Share price and insider trades

ATYR closeInsider buyInsider sale
0.000.250.500.751.001.25NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $6,293 on 2026-02-04 · Jill Marie Broadfoot, Nancy Denyes, Sanjay ShuklaBought $50,000 on 2026-05-27 · Paul SchimmelBought $298,919 on 2025-10-09 · Paul Schimmel
Bought, 12 months$963K
Sold, 12 months$6K
Insiders buying1
Insiders selling3

aTYR PHARMA insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $963K and 3 sold $6K of ATYR stock on the open market.

ATYR insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $913K bought (2 trades)$913KQ4 2025Q1 2026: $6K sold (3 trades)Q1 2026Q2 2026: $50K bought (1 trades)$50KQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$50K1—0
Q1 2026—0$6K3
Q4 2025$913K2—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.4×Last 5 sessions
Insiders' paper profit−$692KOn all tracked purchases -71.9%

Summary

Over the past 12 months, 1 aTYR PHARMA INC insider reported open-market purchases totaling $963K, while 3 insiders reported sales totaling $6K. Among insiders with enough purchase history to measure, Paul Schimmel (Director) has the highest Insider Score at 39. 0 of 3 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
May 28SEC Paul SchimmelDirector Buy 100,000779,143 held (+15%) $0.50 $50K -50.8% 39
Feb 4SEC Sanjay ShuklaCEO, President Sell 3,745153,553 held (−2%) $0.98 $4K -74.9% —
Feb 4SEC Jill Marie BroadfootCFO Sell 1,55837,296 held (−4%) $0.98 $2K -74.9% —
Feb 4SEC Nancy DenyesGeneral Counsel Sell 1,11833,124 held (−3%) $0.98 $1K -74.9% —
Oct 9SEC Paul SchimmelDirector Buy 682,0011,095,024 held (+165%) $0.90 $614K -72.7% 39
Oct 9SEC Paul SchimmelDirector Buy 317,9991,413,023 held (+29%) $0.94 $299K -73.8% 39

Insiders at aTYR PHARMA INC

InsiderBoughtSoldLast filingScore
Paul SchimmelDirector $963K — May 28, 2026 39
Sanjay ShuklaCEO, President — $4K Feb 4, 2026 —
Jill Marie BroadfootCFO — $2K Feb 4, 2026 —
Nancy DenyesGeneral Counsel — $1K Feb 4, 2026 —

ATYR stock: common questions

Are aTYR PHARMA INC insiders buying ATYR stock?

In the past 12 months, 1 insiders reported open-market purchases of ATYR worth $963K. The latest was Director Paul Schimmel bought $50K of ATYR at $0.50.

Are aTYR PHARMA INC insiders selling ATYR stock?

3 insiders reported sales worth $6K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ATYR's 52-week range?

Over the past year ATYR has traded between $0.25 and $1.06. It last closed at $0.25 on Oct 9, 2026.